Search
Patexia Research
Case number IPR2022-01524

Apotex Inc. et al. v. Regeneron Pharmaceuticals, Inc. > Documents

Date Field Doc. No.PartyDescription
Mar 10, 2023 9 board Download
Jan 26, 2023 8 patent_own Patent Owner's Updated Mandatory Notices Download
Dec 23, 2022 2001 patent_own Scheduling Order, Regeneron Pharms., Inc. v. Mylan Pharms. Inc., Case No. 1:22-cv-00061-TSK Download
Dec 23, 2022 2003 patent_own Decision, Mylan Pharms. Inc. v. Regeneron Pharms., Inc., IPR2021-00881 Download
Dec 23, 2022 2006 patent_own File History of U.S. Patent 9,669,069 Download
Dec 23, 2022 2007 patent_own File History of U.S. Patent 10,130,681 Download
Dec 23, 2022 2008 patent_own File History of U.S. Patent 10,857,205 (Part 6 of 7) Download
Dec 23, 2022 2008 patent_own File History of U.S. Patent 10,857,205 (Part 2 of 7) Download
Dec 23, 2022 2009 patent_own File History of U.S. Patent 10,888,601 Download
Dec 23, 2022 2010 patent_own File History of U.S. Patent Application 17/072,417 Download
Dec 23, 2022 2011 patent_own File History of U.S. Patent Application 17/112,404 Download
Dec 23, 2022 2012 patent_own File History of U.S. Patent Application 17/350,958 Download
Dec 23, 2022 2013 patent_own File History of U.S. Patent 11,253,572 (Part 1 of 2) Download
Dec 23, 2022 2013 patent_own File History of U.S. Patent 11,253,572 (Part 2 of 2) Download
Dec 23, 2022 2014 patent_own Download
Dec 23, 2022 2015 patent_own Complaint, Regeneron Pharms., Inc. v. Mylan Pharms. Inc., Case No. 1:22-cv-00061-TSK Download
Dec 23, 2022 2016 patent_own Download
Dec 23, 2022 2017 patent_own Download
Dec 23, 2022 2018 patent_own Dec. 12. 2022 Letter to Neil B. McLaughlin from Thomas S. Fletcher Regarding Narrowing the Case, Mylan Pharms. Inc. v. Regeneron Pharms, Inc., Case No. 1:22-cv-00061-TSK Download
Dec 23, 2022 2021 patent_own Expert Declaration of Lucian V. Del Priore, M.D., Ph.D. (Redacted Copy), Mylan Pharms. Inc. v. Regeneron Pharms, Inc., IPR2021-00881, Exhibit No. 2048 Download
Dec 23, 2022 2022 patent_own Eylea (aflibercept) Injection label, revised May 2016 Download
Dec 23, 2022 2024 patent_own CENTER FOR DRUG EVALUATION & RESEARCH, Medical Review, BLA No. 125156 Download
Dec 23, 2022 2025 patent_own Mansour et al., Long-term Visual Outcomes of Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization, 148 AM. J. OPTHAMOLOGY. 310 (2009) Download
Dec 23, 2022 2026 patent_own Lott et al., Bevacizumab in Inflammatory Eye Disease, 148 AM. J. OPTHAMOLOGY. 711 (2009) Download
Dec 23, 2022 2028 patent_own Download
Dec 23, 2022 2029 patent_own Petition for Inter Partes Review of U.S. Patent No. 9,669,069 B2, Mylan Pharms. Inc. v. Regeneron Pharms., Inc., IPR2021-00880 Download
Dec 23, 2022 2031 patent_own Petition for Inter Partes Review of U.S. Patent No. 9,254,338 B2, Mylan Pharms. Inc. v. Regeneron Pharms., Inc, IPR2021-00881 Download
Dec 23, 2022 6 patent_own Patent Owner's Preliminary Response Download
Dec 23, 2022 2002 patent_own Expert Declaration of Richard Manning, Ph.D. (Redacted Copy) Download
Dec 23, 2022 2004 patent_own Decision, Mylan Pharms. Inc. v. Regeneron Pharms., Inc., IPR2021-00880 Download
Dec 23, 2022 2005 patent_own File History of U.S. Patent 10,828,345 B2 Download
Dec 23, 2022 2008 patent_own File History of U.S. Patent 10,857,205 (Part 3 of 7) Download
Dec 23, 2022 2008 patent_own File History of U.S. Patent 10,857,205 (Part 5 of 7) Download
Dec 23, 2022 2008 patent_own File History of U.S. Patent 10,857,205 (Part 7 of 7) Download
Dec 23, 2022 2008 patent_own File History of U.S. Patent 10,857,205 (Part 1 of 7) Download
Dec 23, 2022 2008 patent_own File History of U.S. Patent 10,857,205 (Part 4 of 7) Download
Dec 23, 2022 2019 patent_own Preliminary Response of Patent Owner Regeneron Pharmaceuticals, Inc., Mylan Pharms. Inc. v. Regeneron Pharms., Inc., IPR2022-01225 Download
Dec 23, 2022 2020 patent_own Jaffe et al., Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid, 123 OPHTHALMOLOGY 1856 (2016) Download
Dec 23, 2022 2023 patent_own Transcript Jan. 20, 2022 Deposition of Thomas Albini, M.D. in Mylan Pharms. Inc. v. Regeneron Pharms, Inc., IPR2021-00880 & IPR2021-00881 Download
Dec 23, 2022 2027 patent_own Motion Requesting Expedited Status Conference, Regeneron Pharms., Inc. v. Mylan Pharms. Inc., Case No. 1:22-cv-00061-TSK Download
Dec 23, 2022 2030 patent_own Petition for Inter Partes Review of U.S. Patent No. 9,669,069 B2, Apotex Inc. v. Regeneron Pharms., Inc., IPR2022-00301 Download
Dec 23, 2022 2032 patent_own etition for Inter Partes Review of U.S. Patent No. 9,254,338 B2, Apotex Inc. v. Regeneron Pharms., Inc., IPR2022-00298 Download
Dec 23, 2022 7 patent_own Patent Owner Preliminary Response Download
Oct 5, 2022 4 patent_own Patent Owner's Power of Attorney Download
Oct 5, 2022 5 patent_own Patent Owner's Mandatory Notices Download
Sep 28, 2022 3 board Notice: Notice filing date accorded Download
Sep 9, 2022 1 petitioner Petition for IPR - US 11,253,572 Download
Sep 9, 2022 1001 petitioner 1001 - 572 patent Download
Sep 9, 2022 1002 petitioner 1002 - Expert Declaration of Angelo P. Tanna, M.D. Download
Sep 9, 2022 1003 petitioner 1003 - CV of Angelo P. Tanna, M.D. Download
Sep 9, 2022 1004 petitioner 1004 - Holash Download
Sep 9, 2022 1005 petitioner 1005 - Nguyen-2009 Download
Sep 9, 2022 1006 petitioner 1006 - Dixon Download
Sep 9, 2022 1007 petitioner 1007 - Adis Download
Sep 9, 2022 1008 petitioner 1008 - Semeraro Download
Sep 9, 2022 1009 petitioner 1009 - Regeneron (8-May-2008) Download
Sep 9, 2022 1010 petitioner 1010 - NCT-795 Download
Sep 9, 2022 1011 petitioner 1011 - NCT-377 Download
Sep 9, 2022 1012 petitioner 1012 - Monthly-Dosing-Patents Download
Sep 9, 2022 1013 petitioner 1013 - 338 FH Download
Sep 9, 2022 1014 petitioner 1014 - Heier-2012 Download
Sep 9, 2022 1015 petitioner 1015 - Heier-2009 Download
Sep 9, 2022 1016 petitioner 1016 - 2009 10-Q Download
Sep 9, 2022 1017 petitioner 1017 - Bayer (8-May-2008) Download
Sep 9, 2022 1018 petitioner 1018 - Brown Download
Sep 9, 2022 1019 petitioner 1019 - Lucentis Download
Sep 9, 2022 1020 petitioner 1020 - Reichert Download
Sep 9, 2022 1021 petitioner 1021 - History-ClinicalTrials.gov Download
Sep 9, 2022 1022 petitioner 1022 - Wayback-Affidavit-038 Download
Sep 9, 2022 1023 petitioner 1023 - Nguyen-2006 Download
Sep 9, 2022 1024 petitioner 1024 - Patent Owner Exhibit 2050 in IPR2021-00881 Download
Sep 9, 2022 1025 petitioner 1025 - Hecht Download
Sep 9, 2022 1026 petitioner 1026 - Rosenfeld Download
Sep 9, 2022 1027 petitioner 1027 - Randolph Download
Sep 9, 2022 1028 petitioner 1028 - Fraser Download
Sep 9, 2022 1029 petitioner 1029 - Saishin Download
Sep 9, 2022 1030 petitioner 1030 - Heier-2012 Appendix Download
Sep 9, 2022 1031 petitioner 1031 - FDA Guidance for Industry Download
Sep 9, 2022 1032 petitioner 1032 - Heimann-2007 Download
Sep 9, 2022 1033 petitioner 1033 - Jager-2004 Download
Sep 9, 2022 1034 petitioner 1034 - NIH AMD Download
Sep 9, 2022 1035 petitioner 1035 - NIH DR Download
Sep 9, 2022 1036 petitioner 1036 - Regeneron (28-April-2008) Download
Sep 9, 2022 1037 petitioner 1037 - Ferrara-2005 Download
Sep 9, 2022 1038 petitioner 1038 - Rudge Download
Sep 9, 2022 1039 petitioner 1039 - NCT-973 Download
Sep 9, 2022 1041 petitioner 1041 - Regeneron (27-March-2007) Download
Sep 9, 2022 1042 petitioner 1042 - Regeneron (2-August-2007) Download
Sep 9, 2022 1043 petitioner 1043 - Regeneron (19-August-2008) Download
Sep 9, 2022 1044 petitioner 1044 - Regeneron (28-September-2008) Download
Sep 9, 2022 1045 petitioner 1045 - Regeneron (30-April-2009) Download
Sep 9, 2022 1046 petitioner 1046 - Regeneron (14-September-2009) Download
Sep 9, 2022 1047 petitioner 1047 - Regeneron (18-February-2010) Download
Sep 9, 2022 1048 petitioner 1048 - Bayer (19-August-2008) Download
Sep 9, 2022 1049 petitioner 1049 - Campochiaro Download
Sep 9, 2022 1050 petitioner 1050 - Hayes Download
Sep 9, 2022 1051 petitioner 1051 - Anderson Download
Sep 9, 2022 1052 petitioner 1052 - Ciulla Download
Sep 9, 2022 1053 petitioner 1053 - Ni Download
Sep 9, 2022 1054 petitioner 1054 - Zarbin Download
Sep 9, 2022 1055 petitioner 1055 - Corporate Finance Institute Download
Sep 9, 2022 1056 petitioner 1056 - Schneider Download
Sep 9, 2022 1057 petitioner 1057 - Kuepper Download
Sep 9, 2022 1058 petitioner 1058 - Zucchi Download
Sep 9, 2022 2 petitioner Petitioner's Power of Attorney Download
Menu